The consensus process also identified areas in need of further research, such as the development and evaluation of diagnostic and outcome questionnaires, agreement of threshold glycaemia levels for reliable diagnosis, evaluation of the therapeutic efficacy of acarbose for symptoms of early dumping syndrome and assessment of the relative efficacy of short-acting versus long-acting somatostatin analogues. This evidence concerns the gene SST and dumping syndrome.